SUN Pharmaceutical Industries Limited Cephalexin Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Cephalexin Export Records India — #4 Exporter, 294 Shipments, $10.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Cephalexin

India Pharmaceutical Trade Intelligence

$349.5M223 Suppliers104 CountriesHS 30042012

ExportsIndia → UNITED STATES82.2%India → SRI LANKA5.2%

ImportsUNITED STATES → India$146.5K CROATIA → India$17.9K

#1 Supplier: ALKEM LABORATORIES #1 Buyer: ASCEND LABORATORIES,

SUN Pharmaceutical Industries Limited — Cephalexin Exporter #4 | $10.6M Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Cephalexin Exporter Profile

Indian Pharmaceutical Exporter · #4 for Cephalexin · $10.6M export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #4 Indian exporter of Cephalexin with $10.6M in export value and 294 verified shipments. SUN Pharmaceutical Industries Limited holds a 3.0% market share in Cephalexin exports across 10 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Cephalexin Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Cephalexin export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Cephalexin?

Country	Value	Shipments	Share
AUSTRALIA	$6.3M	174	77.5%
NIGERIA	$657.9K	47	8.1%
SOUTH AFRICA	$508.9K	30	6.3%
MYANMAR	$181.2K	12	2.2%
THAILAND	$169.4K	19

Who Are the Top Buyers of Cephalexin from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
M/S. SUN PHARMA ANZ PTY LTD	AUSTRALIA	$3.2M	95
M S SUN PHARMA ANZ PTY LIMITED	AUSTRALIA	$1.5M	33
M S SUN PHARMA ANZ PTY LTD	AUSTRALIA	$629.8K	16
M/S. SUN PHARMA ANZ PTY .LTD	AUSTRALIA	$468.7K	14
MS SUN PHARMA ANZ PTY LIMITED	AUSTRALIA	$272.6K	11
M/S. SANKIL PHARMACEUTICAL LTD.	NIGERIA	$183.5K	13
M/S. RANBAXY NIGERIA LIMITED	NIGERIA	$175.4K	16
M S SANKIL PHARMACEUTICAL LTD	NIGERIA	$173.4K	11
SUN PHARMA ANZ PTY LIMITED	AUSTRALIA	$168.1K	5
M S RANBAXY PHARMACEUTICALS PTY LIMITED	SOUTH AFRICA	$107.4K	5

SUN Pharmaceutical Industries Limited supplies Cephalexin to 44 buyers globally. The largest buyer is M/S. SUN PHARMA ANZ PTY LTD (AUSTRALIA), followed by M S SUN PHARMA ANZ PTY LIMITED (AUSTRALIA) and M S SUN PHARMA ANZ PTY LTD (AUSTRALIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Cephalexin Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
APO-CEPHALEXIN CAP 500MG PACK:BOX20s BAT	$610.5K	14
APO-CEPHALEXIN CAP 250MG PACK:BOX20s BAT	$247.3K	9
APO-CEPHALEXIN CAP 500MG PACK: Box20s BA	$219.7K	5
APO-CEPHALEXIN CAP 500MG PACK:BOX20S BATCH:DFE8555A, DFE8556A EACH CAP CONTS.CEPHALEXIN BP EQ TO ANHYDROUS CEPHALEXIN 50NOS	$81.5K	3
APO-CEPHALEXIN CAP 500MG PACK:BOX20S BATCH:DFF0031A, DFF0065A EACH CAP CONTS.CEPHALEXIN BP EQ TO ANHYDROUS CEPHALEXIN 50NOS	$80.8K	3
APO-CEPHALEXIN CAP 500MG PACK:BOX20S BATCH:DFE8192A,DFE8193A EACH CAP CONTS.CEPHALEXIN BP EQ TO ANHYDROUS CEPHALEXIN 500NOS	$76.4K	3
APO-CEPHALEXIN CAP 500MG PACK:BOX20S BATCH:DFF3287A EACH CAP CONTS. CEPHALEXIN BP EQ TO ANHYDROUS CEPHALEXIN 500MG	$57.6K	2
APO-CEPHALEXIN CAP 250MG PACK:BOX20S BATCH:DFE8269A EACH CAP CONTS.CEPHALEXIN BPEQ TO ANHYDROUS CEPHALEXIN 250MGNOS	$52.8K	3
APO CEPHALEXIN CAP 500MG PACK Box20s Batch DFE0817A DFE1108A EACH CAP CONTSCEPHALEXIN BP EQ TO ANHYDROUS CEPHALEXI	$50.0K	1
APO CEPHALEXIN CAP 500MG PACK Box20s Batch DFE1109A DFE1144A EACH CAP CONTSCEPHALEXIN BP EQ TO ANHYDROUS CEPHALEXI	$50.0K	1

SUN Pharmaceutical Industries Limited exports 228 distinct Cephalexin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is APO-CEPHALEXIN CAP 500MG PACK:BOX20s BAT with 14 shipments worth $610.5K.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Cephalexin Exporters?

Exporters ranked immediately above and below #4 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	LUPIN LIMITED	$30.1M	601	7	$50.0K
3	AUROBINDO PHARMA LTD	$11.8M	242	5	$48.7K
4	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$10.6M	294	10	$36.1K
5	CIPLA LIMITED	$9.2M	184	3	$50.0K
8	SANCE LABORATORIES PRIVATE LIMITED	$3.6M	72	8	$50.0K

SUN Pharmaceutical Industries Limited ranks #4 among 223 Indian Cephalexin exporters. Average shipment value of $36.1K compared to the market average of $488.4K. The closest competitors by value are LUPIN LIMITED and AUROBINDO PHARMA LTD.

Which Indian Ports Ship Cephalexin Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	873	17.1%
SAHAR AIR	744	14.5%
DELHI AIR CARGO ACC (INDEL4)	538	10.5%
NHAVA SHEVA SEA (INNSA1)	398	7.8%
DELHI AIR	340	6.6%
JNPT/ NHAVA SHEVA SEA	275	5.4%
JNPT	220	4.3%
Bombay Air	163	3.2%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Cephalexin Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Cephalexin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 305 individual customs records matching SUN Pharmaceutical Industries Limited exporting Cephalexin, covering 228 formulations to 10 countries via 44 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 104+ countries, 516+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Cephalexin

Cephalexin

SUN Pharmaceutical Industries Limited — Cephalexin Exporter Profile

SUN Pharmaceutical Industries Limited — Cephalexin Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Cephalexin?

Who Are the Top Buyers of Cephalexin from SUN Pharmaceutical Industries Limited?

What Is India's Total Cephalexin Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Cephalexin Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Cephalexin Exporters?

What Cephalexin Formulations Does SUN Pharmaceutical Industries Limited Export?

Regulatory Requirements: Exporting Cephalexin to Key Markets

Australia — TGA

Nigeria — NAFDAC

South Africa — SAHPRA

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Cephalexin Exporters?

Which Indian Ports Ship Cephalexin Exports?

What Other Antibiotics Products Does SUN Pharmaceutical Industries Limited Export?

Cephalexin — Export Intelligence Video

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Cephalexin Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Cephalexin Export Data from SUN Pharmaceutical Industries Limited

Cephalexin Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source